Search research articles
Contact Us
Filters
Showing results (81-90 of 139) with videos related to
Page
of 14
Sort By:
Annals of Internal Medicine
|
April 29, 2024
Medicare Negotiation's Drug Reformulation Problem
Matthew Vogel, Benjamin N Rome, Aaron S Kesselheim, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
June 13, 2021
Factors Associated With Generic Drug Uptake in the United States, 2012 to 2017
Benjamin N Rome, ChangWon C Lee, Joshua J Gagne, et al.
JAMA Neurology
|
November 27, 2023
Potential Medicare and Medicaid Savings on Anti-CD20 Therapy for Multiple Sclerosis
John Kim, Aaron S Kesselheim, Riley Bove, et al.
JAMA
|
March 25, 2026
National Prescribing Trends of Direct-Acting Antivirals for Hepatitis C
Sanjay Kishore, Margaret Hayden, Micah Johnson, et al.
JAMA
|
October 21, 2024
Strategies to Help Patients Navigate High Prescription Drug Costs
Hussain S Lalani, Catherine S Hwang, Aaron S Kesselheim, et al.
JAMA Health Forum
|
March 29, 2024
Patient Out-of-Pocket Costs for Biologic Drugs After Biosimilar Competition
Kimberly Feng, Massimiliano Russo, Luca Maini, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
October 20, 2022
Using Multiple Authorized Generics to Maintain High Prices: The Example of Entacapone
Benjamin N Rome, Alexander C Egilman, Neeraj G Patel, et al.
JAMA Network Open
|
May 4, 2021
Correlation Between Changes in Brand-Name Drug Prices and Patient Out-of-Pocket Costs
Benjamin N Rome, William B Feldman, Rishi J Desai, et al.
Journal of General Internal Medicine
|
July 19, 2024
Shortages of Essential Generic Drugs with Limited Competition
Matthew J Martin, Benjamin N Rome, Aaron S Kesselheim, et al.
The Oncologist
|
June 14, 2025
Medicare spending and use of subcutaneous biologic formulations with hyaluronidase
John Kim, Aaron S Kesselheim, Edward R Scheffer Cliff, et al.
Page
of 14
Search research articles
Search
Showing results (81-90 of 139) with videos related to
Sort By:
Page
of 14
Annals of Internal Medicine
|
April 29, 2024
Medicare Negotiation's Drug Reformulation Problem
Matthew Vogel, Benjamin N Rome, Aaron S Kesselheim, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
June 13, 2021
Factors Associated With Generic Drug Uptake in the United States, 2012 to 2017
Benjamin N Rome, ChangWon C Lee, Joshua J Gagne, et al.
JAMA Neurology
|
November 27, 2023
Potential Medicare and Medicaid Savings on Anti-CD20 Therapy for Multiple Sclerosis
John Kim, Aaron S Kesselheim, Riley Bove, et al.
JAMA
|
March 25, 2026
National Prescribing Trends of Direct-Acting Antivirals for Hepatitis C
Sanjay Kishore, Margaret Hayden, Micah Johnson, et al.
JAMA
|
October 21, 2024
Strategies to Help Patients Navigate High Prescription Drug Costs
Hussain S Lalani, Catherine S Hwang, Aaron S Kesselheim, et al.
JAMA Health Forum
|
March 29, 2024
Patient Out-of-Pocket Costs for Biologic Drugs After Biosimilar Competition
Kimberly Feng, Massimiliano Russo, Luca Maini, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
October 20, 2022
Using Multiple Authorized Generics to Maintain High Prices: The Example of Entacapone
Benjamin N Rome, Alexander C Egilman, Neeraj G Patel, et al.
JAMA Network Open
|
May 4, 2021
Correlation Between Changes in Brand-Name Drug Prices and Patient Out-of-Pocket Costs
Benjamin N Rome, William B Feldman, Rishi J Desai, et al.
Journal of General Internal Medicine
|
July 19, 2024
Shortages of Essential Generic Drugs with Limited Competition
Matthew J Martin, Benjamin N Rome, Aaron S Kesselheim, et al.
The Oncologist
|
June 14, 2025
Medicare spending and use of subcutaneous biologic formulations with hyaluronidase
John Kim, Aaron S Kesselheim, Edward R Scheffer Cliff, et al.
Page
of 14